Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) has a cash flow conversion efficiency ratio of -0.738x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.73 Million) by net assets ($5.06 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cuprina Holdings (Cayman) Limited Class (CUPR) balance sheet quality index to measure how much of total assets are equity-financed.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore CUPR long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CDT Environmental Technology Investment Holdings Limited ordinary shares
NASDAQ:CDTG
|
-0.023x |
|
CVC Income & Growth Limited
LSE:CVCG
|
0.019x |
|
Global Health Ltd
AU:GLH
|
0.017x |
|
JPMorgan China Growth & Income PLC
LSE:JCGI
|
0.008x |
|
Fuller Smith & Turner
LSE:FSTA
|
0.093x |
|
Transition Evergreen
PA:EGR
|
0.008x |
|
Laxmi Cotspin Limited
NSE:LAXMICOT
|
0.025x |
|
Bridge Saas Ltd
AU:BGE
|
0.026x |
Annual Cash Flow Conversion Efficiency for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2021–2025)
The table below shows the annual cash flow conversion efficiency of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see Cuprina Holdings (Cayman) Limited Class (CUPR) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $5.06 Million | $-9.13 Million | -1.807x | -751.92% |
| 2024-12-31 | $-4.46 Million | $-1.24 Million | 0.277x | -47.95% |
| 2023-12-31 | $-2.90 Million | $-1.54 Million | 0.532x | -48.81% |
| 2022-12-31 | $-1.78 Million | $-1.85 Million | 1.040x | +220.45% |
| 2021-12-31 | $-683.52K | $-221.86K | 0.325x | -- |
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collag… Read more